Your browser doesn't support javascript.
loading
Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks.
Kerbusch, T; Groenewegen, G; Mathôt, R A A; Herben, V M M; ten Bokkel Huinink, W W; Swart, M; Ambaum, B; Rosing, H; Jansen, S; Voest, E E; Beijnen, J H; Schellens, J H M.
Affiliation
  • Kerbusch T; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. thomas_kerbusch@sandwich.pfizer.com
Br J Cancer ; 90(12): 2268-77, 2004 Jun 14.
Article in En | MEDLINE | ID: mdl-15150579
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2004 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2004 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido